文献速递外周动脉疾病

高龄严重肢体缺血患者临终前生活质量与健康状况的前瞻性研究

Is a Good Quality of Life and Health Status Possible in Older Patients Dying from Critical Limb-Threatening Ischemia: A Prospective Clinical Study.
PubMed 文献 · Ann Vasc Surg · 2019-10-19

结果显示,无论接受腔内、外科或保守治疗,患者临终前生活质量与健康状况较之前测量均未下降;除心理健康领域外,各治疗组出现显著个体变化的比例无差异。

要点

  • 高龄CLTI患者临终前生活质量与健康状况未因治疗方式而下降。
  • 除心理健康外,各治疗组显著个体变化比例无差异。
  • 临床决策应使用患者报告结局指标进行共享决策。

核心结论

  • 高龄CLTI且预期寿命不足2年的患者,临终前生活质量与健康状况较之前测量无差异。
  • 除心理健康领域外,各治疗组出现显著个体变化的比例无差异。

研究设计与样本

  • 治疗方式包括腔内血运重建、外科血运重建或保守治疗,于6个指定时间点完成WHOQOL-BREF和SF-12问卷。

主要发现

  • 临终前生活质量与健康状况未随治疗方式(腔内、外科或保守)而下降。
  • 除心理健康领域外,各治疗组出现显著个体变化的比例无差异。

临床怎么用

  • 对高龄虚弱CLTI患者讨论治疗时,应使用患者报告结局指标进行共享决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Revascularization is the cornerstone in the treatment of patients with critical limb-threatening ischemia (CLTI). However, the 2-year mortality rate is up to 50% in these patients. Therefore, the clinical benefit of revascularization needs to be considered carefully. The question emerges if there are changes in quality of life (QoL) and health status (HS) in the end-of-life phase of CLTI in older patients. METHODS: Patients with CLTI and of an age of 70 years or older were included in a prospective observational cohort study. Treatment consisted of endovascular revascularization, surgical revascularization, or conservative therapy. The follow-up period was 2 years. Within this follow-up period, patients completed the following questionnaires at six specified time intervals: the WHOQOL-BREF and the SF-12. Patients who died within 2 years after inclusion were analyzed. Final scores were defined as the last measurement at end of follow-up or death. RESULTS: Eighty two patients (42.1%) died during the 24-month follow-up. QoL and HS before death did not decrease with treatment (option: endovascular intervention, surgical revascularization, or conservative therapy). CONCLUSIONS: Older patients with CLTI and a life expectancy less than 2 years had no differences in QoL and HS before death compared to their previous measurement. Except for the mental HS domain, no differences in the percentage of patients showing significant individual change in QoL and HS were found between the treatments. For clinicians, it is important to use patient-reported outcome measure when discussing treatment for older frail patients with CLTI in a shared decision-making process.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Peters CML, de Vries J, Lodder P, et al. Is a Good Quality of Life and Health Status Possible in Older Patients Dying from Critical Limb-Threatening Ischemia: A Prospective Clinical Study. Ann Vasc Surg. 2019. PMID: 31639483. doi:10.1016/j.avsg.2019.10.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。